Evolutionary Tree Capital Management’s DexCom DXCM Stock Holding History

Evolutionary Tree Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,967	Closed	-$2.26M	–	34
2024 Q2	$2.26M	Buy	+19,967	New	+$2.52M	2.33%	18
2022 Q3	–	Sell	-28,693	Closed	-$2.14M	–	35
2022 Q2	$2.14M	Buy	28,693 +6,565	+30%	+$599K	2.33%	20
2022 Q1	$2.83M	Sell	22,128 -1,292	-6%	-$141K	1.97%	25
2021 Q4	$3.14M	Sell	23,420 -1,660	-7%	-$239K	1.51%	27
2021 Q3	$3.43M	Sell	25,080 -1,984	-7%	-$250K	1.52%	31
2021 Q2	$2.89M	Buy	27,064 +804	+3%	+$77.2K	1.33%	32
2021 Q1	$2.36M	Buy	26,260 +13,436	+105%	+$1.26M	1.39%	28
2020 Q4	$1.19M	Buy	+12,824	New	+$1.15M	0.9%	34

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Evolutionary Tree Capital Management's DXCM Position: Q3 2024 in Review

Evolutionary Tree Capital Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 19,967 shares — an estimated $2.26M sold.

Evolutionary Tree Capital Management first reported a position in DXCM in Q4 2020 and held it in 8 quarters. The position peaked at $3.43M in Q3 2021. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Evolutionary Tree Capital Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Evolutionary Tree Capital Management sold 19,967 DexCom shares in Q3 2024, an estimated $2.26M.
Evolutionary Tree Capital Management first reported a position in DexCom in Q4 2020 and held it in 8 quarters.
Evolutionary Tree Capital Management's DexCom position peaked at $3.43M in Q3 2021.
889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Evolutionary Tree Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.